Craft

Encycle Therapeutics

Total Funding

$4.6 M

Encycle Therapeutics Summary

Company Summary

Overview
A proprietary chemistry platform from the laboratory of Dr. Andrei Yudin at the University of Toronto allows efficient synthesis of uniquely substituted ring systems comprising six to twenty or more contiguous atoms. Our core Discovery capability focuses on the design of molecules that address emerging principles in the chemical space required to mediate protein-protein interactions. The company's collaborative programs reflect the evolving understanding in this space and in the identification of key drug targets.
Type
Private
Status
Active
Founded
2012
HQ
Toronto, CA | view all locations
Website
http://encycletherapeutics.com/
Cybersecurity rating
Sectors

Key People

  • Jeffrey Coull, President and CEO

    • Andrei Yudin, Scientific Founder, SAB

      • Raphael Hofstein, Chairman

        LocationsView all

        1 location detected

        • Toronto, Ontario HQ

          Canada

          314 101 College St

        Footer menu